Endogenous corticosteroids modulate Clostridium difficile toxin A-induced enteritis in rats

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 280, Issue 4 43-4, 2001, Pages

  Castagliuolo, Ignazio ^a   Karalis, Katia ^a   Valenick, Leyla ^a   Pasha, Asiya ^a   Nikulasson, Sigfus ^b   Wlk, Michael ^a   Pothoulakis, Charalabos ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bacterial enterotoxins; Hypothalamic pituitary adrenal axis; Macrophage inflammatory protein 2

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN A; DEXAMETHASONE; GLUCOCORTICOID; MACROPHAGE INFLAMMATORY PROTEIN 2; MIFEPRISTONE;

ADRENALECTOMY; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORTICOSTEROID BLOOD LEVEL; DIARRHEA; DOWN REGULATION; ENTERITIS; INTESTINE SECRETION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT;

EID: 0035010312     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.2001.280.4.g539     Document Type: Article

References (50)

1. Abe R, Shimosegawa T, Kimura K, Abe T, Kashimura J, Koizumi M, and Toyota T. The role of endogenous glucocorticoids in rat experimental models of acute pancreatitis. Gastroenterology 109: 933-943, 1995.
2. Akana SF, Cascio SS, Shinsako J, and Dallman MF. Corticosterone: narrow range required for normal body and thymus weight and ACTH. Am J Physiol Regulatory Integrative Comp Physiol 249: R527-R532, 1985.
3. Andreis PG, Neri G, Belloni AS, Mazzocchi G, Kasprzak A, and Nussdorfer GG. Interleukin-1 beta enhances corticosterone secretion by acting directly on the rat adrenal gland. Endocrinology 129: 53-57, 1991.
4. Auphan N, DiDonato JA, Rosette C, Helmberg A, and Karin MM. Immunosuppression by glucocorticoids: inhibition of NFkB activity through induction of IkB synthesis. Science 270: 286-290, 1995.
5. Besedovsky AH, Del Ray A, Sorkin E, and Dinarello CA. Immunoregulatory feedback between interleukin1 and glucocorticoid hormones. Science 233: 652-655, 1986.
6. Boumpas DT, Chrousos GP, Wilder RL, Cupps TR, and Balar JE. Glucocorticoid therapy for immune mediated diseases: basic and clinical correlates. Ann Intern Med 119: 1198-1208, 1993.
7. Castagliuolo I, Keates AC, Qiu BS, Kelly CP, Nikulasson ST, Leeman SE, and Pothoulakis C. Increased substance P responses in dorsal root ganglia and intestinal macrophages during Clostridium difficile toxin A enteritis in rats. Proc Natl Acad Sci USA 94: 4788-4793, 1997.
8. Castagliuolo I, Keates AC, Wang CC, Pasha A, Valenick L, Kelly CP, Nikulasson ST, LaMont JT, and Pothoulakis C. Clostridium difficile toxin A stimulates macrophage inflammatory protein-2 production in rat intestinal epithelial cells. J Immunol 160: 6039-6045, 1998.
9. Castagliuolo I, Kelly CP, Qiu BS, Nikulasson ST, LaMont JT, and Pothoulakis C. IL-11 inhibits Clostridium difficile toxin A enterotoxicity in rat ileum. Am J Physiol Gastrointest Liver Physiol 273: G333-G341, 1997.
10. Castagliuolo I, LaMont JT, Letourneau R, Kelly CP, O'Keane JC, Jaffer A, Theoharides TC, and Pothoulakis C. Neuronal involvement in the intestinal effects of Clostridium difficile toxin A and Vibrio cholerae enterotoxin. Gastroenterology 107: 657-665, 1994.
11. Castagliuolo I, Wershil BK, Karalis K, Pasha A, Nikulasson ST, and Pothoulakis C. Colonic mucin release in response to immobilization stress is mast cell dependent. Am J Physiol Gastrointest Liver Physiol 274: G1094-G1100, 1998.
12. Dallman MF, Akana SF, Bhatnagar S, Bell ME, Choi S, Chu A, Horsley C, Levin N, Meijer O, Soriano LR, Strack AM, and Viau V. Starvation: early signals, sensors, and sequelae. Endocrinology 140: 4015-4023, 1999.
13. Dillon ST, Rubin E, Yakubovich M, Pothoulakis C, LaMont JT, Feig LA, and Gilbert RJ. Involvement of ras-related Rho proteins in the mechanisms of action of Clostridium difficile toxin A and toxin B. Infect Immun 63: 1421-1426, 1995.
14. Dove ST, Price SB, Phelps CJ, Lyerly DM, Wilkins TD, and Johnson JL. Molecular characterization of the Clostridium difficile toxin A gene. Infect Immun 58: 480-488, 1990.
15. Fauci AS. Immunosuppressive and anti-inflammatory effects of glucocorticoids. In: Glucocorticoid Hormone Action, edited by Baxter D and Rousseau S. Berlin: Springer-Verlag, 1989, p. 449-465.
16. Haddad E-B, Salmon M, Sun J, Liu S, Das A, Adcock I, Barnes PJ, and Chung KF. Dexamethazone inhibits ozone-induced gene expression of macrophage inflammatory protein-2 in rat lung. FEBS Lett 363: 285-288, 1995.
17. Hecht G, Pothoulakis C, LaMont JT, and Madara JL. Clostridium difficile toxin A perturbs cytoskeletal and tight junction permeability of cultured human intestinal monolayers. J Clin Invest 82: 1516-1524, 1988.
18. Jacobson L and Sapolsky RM. Augmented ACTH responses to stress in adrenalectomized rats replaced with constant, physiological levels of corticosterone are partially normalized by acute increases in corticosterone. Neuroendocrinology 58: 420-429, 1993.
19. Jacobson L, Zurakowski D, and Majzoub JA. Protein malnutrition increases plasma ACTH and anterior pituitary POMC ribonucleic acid in the rat. Endocrinology 138: 1048-1057, 1997.
20. Jobin C, Haskill S, Mayer L, Panja A, and Sartor RB. Evidence for altered regulation of I kappa B alpha degradation in human colonic epithelial cells. J Immunol 158: 226-234, 1997.
21. Just I, Wilm M, Selzer J, Rex G, Eichel-Streiber C, Mann M, and Aktories K. The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins. J Biol Chem 270: 13932-13936, 1995.
22. Karalis K, Crofford L, Wilder RL, and Chrousos GP. Glucocorticoid and/or glucocorticoid antagonist effects in inflammatory disease-susceptible Lewis rats and inflammatory disease-resistant Fischer rats. Endocrinology 136: 3107-3112, 1995.
23. Keates AC, Castagliuolo I, Qiu B, Nikulasson ST, Sengupta A, and Pothoulakis C. CGRP upregulation in dorsal root ganglia and ileal mucosa during Clostridium difficile toxin A-induced enteritis. Am J Physiol Gastrointest Liver Physiol 274: G196-G202, 1998.
24. Kelly CP, Becker SD, Linevsky JK, Joshi MA, O'Keane JK, Dickey BF, LaMont JT, and Pothoulakis C. Neutrophil recruitment in Clostridium difficile toxin A enteritis. J Clin Invest 93: 1257-1265, 1994.
25. Kimura K, Shimosegawa T, Sasano H, Abe R, Satoh A, Masamune A, Koizumi M, Nagura H, and Toyota T. Endogenous glucocorticoids decrease the acinar cell sensitivity to apoptosis during cerulein pancreatitis in rats. Gastroenterology 114: 372-381, 1989.
26. Kurose I, Pothoulakis C, LaMont JT, Anderson DC, Paulson JC, Miyasaka M, Wolf R, and Granger N. Clostridium difficile toxin A-induced microvascular dysfunction. J Clin Invest 94: 1919-1926, 1994.
27. Mantyh CR, Pappas TN, Lapp JA, Washington MK, Neville LM, Chilardi JR, Rogers SD, Mantyh PW, and Vigna SR. Substance P activation of enteric neurons in response to intraluminal Clostridium difficile toxin A in rat ileum. Gastroenterology 111: 1272-1280, 1996.
28. Mitchell TJ, Ketley M, Haslam SC, Stephen DW, Burton DC, Candy A, and Daniel R. Effect of toxins A and B of Clostridium difficile on rabbit ileum and colon. Gut 27: 78-85, 1986.
29. Moberg GP. Site of action of endotoxin on hypothalamic-pituitary-adrenal axis. Am J Physiol 220: 397-400, 1971.
30. Muller JM, Ziegler V, Heitbrock HW, and Bauerle PA. Nuclear factor kappa B, a mediator of lipopolysaccharide effects. Immunobiology 187: 233-240, 1993.
31. Munck A, Guyre PM, and Holbrook NJ. Physiological functions of glucocorticoids in stress and their relationship to pharmacological actions. Endocr Rev 5: 25-44, 1984.
32. Pothoulakis C, Castagliuolo I, and LaMont JT. Neurons and mast cells modulate secretory and inflammatory responses to enterotoxins. News Physiol Sci 13: 58-63, 1998.
33. Pothoulakis C, Castagliuolo I, Leeman SE, Wang CC, Li H, Hoffman BJ, and Mezey E. Increased substance P receptor expression in intestinal epithelial cells during Clostridium difficile toxin A enteritis in rats. Am J Physiol Gastrointest Liver Physiol 275: G68-G75, 1998.
34. Pothoulakis C, Gilbert RJ, Cladaras C, Castagliuolo I, Semenza G, Hitti Y, Montcrief JS, Linevsky J, Kelly CP, Nikulasson S, Himanshu PD, Wilkins TD, and LaMont JT. Rabbit sucrase-isomaltase contains a functional receptor for Clostridium difficile toxin A. J Clin Invest 98: 641-649, 1996.
35. Pothoulakis C, Karmeli F, Kelly CP, Eliakim R, Joshi MA, O'Keane CJ, Castagliuolo I, LaMont JT, and Rachmilewitz D. Ketotifen inhibits Clostridium difficile toxin A-induced enteritis in rat ileum. Gastroenterology 105: 701-707, 1993.
36. Pothoulakis C, LaMont JT, Eglow RL, Gao N, Rubins JB, Theoharides TC, and Dickey BF. Characterization of rabbit ileal receptors for Clostridium difficile toxin A. Evidence for a receptor-coupled G-protein. J Clin Invest 88: 119-125, 1991.
37. Qiu B, Pothoulakis C, Castagliuolo I, Nikulasson S, and LaMont JT. Participation of reactive oxygen metabolites in Clostridium difficile toxin A-induced enteritis in rats. Am J Physiol Gastrointest Liver Physiol 276: G485-G490, 1999.
38. Riegler M, Sedivy R, Pothoulakis C, Hamilton G, Zacheri J, Biscof G, Cosentini E, Feil W, Schiessel R, LaMont JT, and Wenzl E. Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro. J Clin Invest 95: 2004-2011, 1995.
39. Sapolsky R, Rivier C, Yamamoto G, Plotsky P, and Vale W. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science 237: 522-525, 1987.
40. Scheinman RI, Cogswell PC, Lofquist AK, and Baldwin AS Jr. Role of transcriptional activation of IkBa in mediation of immunosuppression by glucocorticoids. Science 270: 283-286, 1995.
41. Smith GD, Secki JR, Sheward WJ, Bennie JG, Carroll SM, Dick H, and Harmar AJ. Effect of adrenalectomy and dexamethasone on neuropeptide content of dorsal root ganglia in the rat. Brain Res 564: 27-30, 1991.
42. Soda K, Kawabori S, Perdue MH, and Bienenstock J. Macrophage engulfment of mucosal mast cells in rats treated with dexamethazone. Gastreonterology 100: 929-937, 1991.
43. Tjandra K, Kubes P, Rioux K, and Swain M. Endogenous glucocorticoids inhibit neutrophil recruitment to inflammatory sites in cholestatic rats. Am J Physiol Gastrointest Liver Physiol 270: G821-G825, 1996.
44. Triadafilopoulos G, Pothoulakis C, O'Brian MJ, and LaMont JT. Differential effects of Clostridium difficile toxins A and B on rabbit ileum. Gastroenterology 93: 273-239, 1987.
45. Triadafilopoulos G, Pothoulakis C, Weiss R, Giampaolo C, and LaMont JT. Comparative study of Clostridium difficile toxin A and cholera toxin in rabbit ileum. Role of prostaglandins and leukotrienes. Gastroenterology 97: 1186-1192, 1989.
46. Warny M, Keates AC, Keates S, Castigliuolo I, Zacks JF, Aboudola S, Qamar A, Pothoulakis C, LaMont JT, and Kelly CP. p38 MAP kinase activation by Clostridium difficile toxin A mediates monocyte necrosis, IL-8 production and enteritis. J Clin Invest 105: 1147-1156, 2000.
47. Wershil B, Castagliuolo I, and Pothoulakis C. Mast cell involvement in Clostridium difficile toxin A-induced intestinal fluid secretion and neutrophil recruitment in mice. Gastroenterology 114: 956-964, 1998.
48. Winter JSD, Gow KW, and Perry Y. A stimulatory effect of IL-1 on adrenocortical cortisol secretion by acting directly on the adrenal gland. Endocrinology 129: 53-60, 1990.
49. Yoshikawa H, Nakajima Y, and Tasaka K. Glucocorticoid suppresses autocrine survival of mast cells by inhibiting IL-4 production and ICAM expression. J Immunol 162: 6162-6170, 1999.
50. Zuckerman SH, Schellhaas J, and Butler LD. Differential regulation of lipopolysaccharide-induced interleukin-1 and TNF synthesis: effects of endogenous and exogenous glucocorticoids and the role of the pituitary-adrenal axis. Eur J Immunol 19: 301-309, 1989.